Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomasMarijana Virijevic, Maja Perunicic-Jovanovic, Irena Djunic, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 17, 2007
Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphomaIrena Djunic, Djordje Ljubomir Jevtovic, Jovan Ranin, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|April 9, 2011
Simultaneous presentation of hairy cell leukemia and metastatic signet ring carcinoma of the stomach diagnosed by bone marrow biopsyMaja Perunicic-Jovanovic, Irena Djunic, Dragica Tomin, et al.Journal of Medical Case Reports|December 5, 2013
Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case reportAna Vidovic, Valentina Arsic-Arsenijevic, Dragica Tomin, et al.Medical Oncology (Northwood, London, England)|January 1, 2013
Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbiditiesIrena Djunic, Nada Suvajdzic-Vukovic, Marijana Virijevic, et al.Medical Oncology (Northwood, London, England)|February 19, 2011
Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemiaIrena Djunic, Marijana Virijevic, Aleksandra Novkovic, et al.Hematology (Amsterdam, Netherlands)|June 6, 2012
Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemiaIrena Djunic, Marijana Virijevic, Aleksandra Novkovic, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 11, 2012
Is there a "gold" standard treatment for patients with isolated myeloid sarcoma?Darko Antic, Ivo Elezovic, Natasa Milic, et al.Clinical Laboratory|September 5, 2014
Comparison of two laboratory assays in monitoring the efficacy of different prophylaxis regimens for severe haemophiliaIrena Djunic, Violeta Dopsaj, Predrag Miljic, et al.International Journal of Molecular Sciences|April 13, 2024
Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal TherapyMarko Jankovic, Tara Knezevic, Ana Tomic, et al.Pageof 2